133 related articles for article (PubMed ID: 7872951)
1. Ethylmorphine O-deethylation in isolated rat hepatocytes. Involvement of codeine O-demethylation enzyme systems.
Xu BQ; Aasmundstad TA; Bjørneboe A; Christophersen AS; Mørland J
Biochem Pharmacol; 1995 Feb; 49(4):453-60. PubMed ID: 7872951
[TBL] [Abstract][Full Text] [Related]
2. Evidence for CYP2D1-mediated primary and secondary O-dealkylation of ethylmorphine and codeine in rat liver microsomes.
Xu BQ; Aasmundstad TA; Christophersen AS; Mørland J; Bjørneboe A
Biochem Pharmacol; 1997 Feb; 53(4):603-9. PubMed ID: 9105413
[TBL] [Abstract][Full Text] [Related]
3. Effects of ethanol on ethylmorphine metabolism in isolated rat hepatocytes: characterization by means of a multicompartmental model.
Xu BQ; Aasmundstad TA; Lillekjendlie B; Bjørneboe A; Christophersen AS; Mørland J
Pharmacol Toxicol; 1997 Apr; 80(4):171-81. PubMed ID: 9140136
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a role of cytochrome P450 2D6 and 3A4 in ethylmorphine metabolism.
Liu Z; Mortimer O; Smith CA; Wolf CR; Rane A
Br J Clin Pharmacol; 1995 Jan; 39(1):77-80. PubMed ID: 7756104
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
Barham HM; Lennard MS; Tucker GT
Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
[TBL] [Abstract][Full Text] [Related]
6. Ethylmorphine metabolism in isolated rat hepatocytes.
Xu BQ; Bjørneboe A; Ripel A; Aasmundstad TA; Christophersen AS; Mørland J
Pharmacol Toxicol; 1993 Jul; 73(1):35-40. PubMed ID: 8234190
[TBL] [Abstract][Full Text] [Related]
7. Thebaine O-demethylation to oripavine: genetic differences between two rat strains.
Mikus G; Somogyi AA; Bochner F; Eichelbaum M
Xenobiotica; 1991 Nov; 21(11):1501-9. PubMed ID: 1763524
[TBL] [Abstract][Full Text] [Related]
8. Primary and secondary oxidative metabolism of dextromethorphan. In vitro studies with female Sprague-Dawley and Dark Agouti rat liver microsomes.
Kerry NL; Somogyi AA; Mikus G; Bochner F
Biochem Pharmacol; 1993 Feb; 45(4):833-9. PubMed ID: 8452558
[TBL] [Abstract][Full Text] [Related]
9. Microsomal codeine N-demethylation: cosegregation with cytochrome P4503A4 activity.
Caraco Y; Tateishi T; Guengerich FP; Wood AJ
Drug Metab Dispos; 1996 Jul; 24(7):761-4. PubMed ID: 8818573
[TBL] [Abstract][Full Text] [Related]
10. The pharmacogenetics of codeine hypoalgesia.
Sindrup SH; Brøsen K
Pharmacogenetics; 1995 Dec; 5(6):335-46. PubMed ID: 8845855
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activity.
Hedenmalm K; Sundgren M; Granberg K; Spigset O; Dahlqvist R
Ther Drug Monit; 1997 Dec; 19(6):643-9. PubMed ID: 9421105
[TBL] [Abstract][Full Text] [Related]
12. The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model.
Cleary J; Mikus G; Somogyi A; Bochner F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1528-34. PubMed ID: 7996467
[TBL] [Abstract][Full Text] [Related]
13. Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.
Muralidharan G; Hawes EM; McKay G; Midha KK
Xenobiotica; 1991 Nov; 21(11):1441-50. PubMed ID: 1763518
[TBL] [Abstract][Full Text] [Related]
14. Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake.
Sindrup SH; Hofmann U; Asmussen J; Mikus G; Brøsen K; Nielsen F; Ingwersen SH; Broen Christensen C
Eur J Clin Pharmacol; 1996; 49(6):503-9. PubMed ID: 8706777
[TBL] [Abstract][Full Text] [Related]
15. Codeine O-demethylation: rat strain differences and the effects of inhibitors.
Mikus G; Somogyi AA; Bochner F; Eichelbaum M
Biochem Pharmacol; 1991 Mar; 41(5):757-62. PubMed ID: 1998530
[TBL] [Abstract][Full Text] [Related]
16. Studies on the N-demethylation and O-de-ethylation of ethylmorphine by hepatic microsomes from male rats.
Thompson JA; Holtzman JL
Drug Metab Dispos; 1977; 5(1):9-14. PubMed ID: 13981
[TBL] [Abstract][Full Text] [Related]
17. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI).
Dayer P; Desmeules J; Leemann T; Striberni R
Biochem Biophys Res Commun; 1988 Apr; 152(1):411-6. PubMed ID: 3358767
[TBL] [Abstract][Full Text] [Related]
18. Oxidative metabolism of cinnarizine in rat liver microsomes.
Kariya S; Isozaki S; Narimatsu S; Suzuki T
Biochem Pharmacol; 1992 Oct; 44(7):1471-4. PubMed ID: 1417969
[TBL] [Abstract][Full Text] [Related]
19. The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.
Kerry NL; Somogyi AA; Bochner F; Mikus G
Br J Clin Pharmacol; 1994 Sep; 38(3):243-8. PubMed ID: 7826826
[TBL] [Abstract][Full Text] [Related]
20. Expression, purification, and characterization of mouse CYP2d22.
Yu AM; Haining RL
Drug Metab Dispos; 2006 Jul; 34(7):1167-74. PubMed ID: 16595712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
